Merck & Co Inc (MRK)

MRK (NYSE:Drugs) EQUITY
$65.60
neg -0.19
-0.29%
Today's Range: 65.52 - 65.93 | MRK Avg Daily Volume: 7,791,100
Last Update: 09/21/17 - 4:00 PM EDT
Volume: 5,876,901
YTD Performance: 12.03%
Open: $65.89
Previous Close: $65.79
52 Week Range: $58.29 - $66.80
Oustanding Shares: 2,727,354,340
Market Cap: 179,869,018,723
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 7 7 7
Moderate Buy 1 1 1 1
Hold 3 3 3 3
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.86 1.79 1.79 1.79
Latest Dividend: 0.47
Latest Dividend Yield: 2.85%
Dividend Ex-Date: 09/14/17
Price Earnings Ratio: 35.65
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
35.65 35.80 36.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
3.56% 6.22% 9.03%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.80 -0.10 -0.03
Net Income -11.60 -0.10 -0.04
EPS -9.60 -0.10 -0.02
Earnings for MRK:
EBITDA 11.47B
Revenue 39.81B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $1.03 $0.95 $3.87 $4.17
Number of Analysts 7 6 9 9
High Estimate $1.07 $0.98 $3.88 $4.45
Low Estimate $0.99 $0.91 $3.85 $4.04
Prior Year $1.07 $0.89 $3.78 $3.87
Growth Rate (Year over Year) -3.74% 7.30% 2.26% 7.79%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
There's one going on now.
As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.
As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.
There are plenty of reasons for the selloff, not the least of which is White House chaos.
The problem for the pessimists is the same one that has plagued them since the election -- the price action is not cooperating.
Because the selloff isn't over.
What a difference 2 years make -- or 17.
MRK has shaped up on the charts.
It just isn't as useful or descriptive right now.

Columnist Conversations

View Chart »  View in New Window »
this chart is showing great bullish signs here, we like this to take out the old high shortly. ...
Now that AAPL has violated the shorter term support, these are the two areas I have to consider for new buy en...
The symmetry is holding up in MCD.  Target 1 is 163.34 if we continue to hold above here!  ...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.